Small CDMO

Solara Active Pharma Sciences Ltd.

SOLARA

Market Cap
₹2,787 Cr.
P/E
0.00

Solara Active Pharma Sciences Ltd.

  • Solara Active Pharma
  • Morepen Laboratories
  • Hester Biosciences
  • TJI Pharma - API & CRAMS

FAQs on Solara Active Pharma Sciences Ltd. Shareprice

Solara Active Pharma has given better returns compared to its competitors.
Solara Active Pharma has grown at ~18.99% over the last 8yrs while peers have grown at a median rate of 13.98%

Solara Active Pharma is not expensive.
Latest PE of Solara Active Pharma is 0, while 3 year average PE is 33.66.
Also latest EV/EBITDA of Solara Active Pharma is 18.21 while 3yr average is 135.

View FAQ's On Business

Growth Table

  • Solara Active Pharma Sciences Ltd.
  • Morepen Laboratories
  • Hester Biosciences

Balance Sheet

  • Solara Active Pharma Sciences Ltd.
  • Morepen Laboratories
  • Hester Biosciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Solara Active Pharma Sciences Ltd.
  • Morepen Laboratories
  • Hester Biosciences

Cash Flow

  • Solara Active Pharma Sciences Ltd.
  • Morepen Laboratories
  • Hester Biosciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Solara Active Pharma Sciences Ltd.
  • Morepen Laboratories
  • Hester Biosciences

Quarterly Results

  • Solara Active Pharma Sciences Ltd.
  • Morepen Laboratories
  • Hester Biosciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Solara Active Pharma Sciences Ltd. Financials

Balance sheet of Solara Active Pharma is strong.
But short term working capital might become an issue for this company.

The net debt of Solara Active Pharma is decreasing.
Latest net debt of Solara Active Pharma is ₹614 Crs as of Mar-26.
This is less than Mar-25 when it was ₹768 Crs.

The profit is oscillating.
The profit of Solara Active Pharma is -₹7.41 Crs for TTM, ₹0.54 Crs for Mar 2025 and -₹567.39 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Solara Active Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech